Regression of early diabetic macular oedema is associated with prevention of dark adaptation
about
Interrelationships between the Retinal Neuroglia and Vasculature in DiabetesVisual Cycle Modulation as an Approach toward Preservation of Retinal IntegrityLow-level night-time light therapy for age-related macular degeneration (ALight): study protocol for a randomized controlled trialSpare the rods and spoil the retina: revisitedA multicentre phase III randomised controlled single-masked clinical trial evaluating the clinical efficacy and safety of light-masks at preventing dark-adaptation in the treatment of early diabetic macular oedema (CLEOPATRA): study protocol for a rPhotoreceptor cells are major contributors to diabetes-induced oxidative stress and local inflammation in the retinaLight adaptation does not prevent early retinal abnormalities in diabetic ratsHypoxia and Dark Adaptation in Diabetic Retinopathy: Interactions, Consequences, and Therapy.Retinal oxygen: from animals to humans.Therapeutic targeting of diabetic retinal neuropathy as a strategy in preventing diabetic retinopathy.Mechanistic Insights into Pathological Changes in the Diabetic Retina: Implications for Targeting Diabetic Retinopathy.Safety and acceptability of an organic light-emitting diode sleep mask as a potential therapy for retinal disease.Do photoreceptor cells cause the development of retinal vascular disease?Loss of CD40 attenuates experimental diabetes-induced retinal inflammation but does not protect mice from electroretinogram defects.New concept: treating nonproliferative diabetic retinopathy with light adaptation of rods during sleep.Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial.
P2860
Q27028003-ED68944A-24AD-4A4C-AA05-CAE926646755Q28547211-6137BC1C-3BCA-47CF-853E-588113EEA6B8Q34486375-5927828F-5C0F-4A2B-B447-EAFE56C0065FQ34504721-2854BAA5-866F-4946-B10E-BFC29C63086BQ34632358-59C20E15-F8A2-406A-A49F-D05293026A7BQ37236350-CA81037D-F903-4429-B21E-7E81F620E2EDQ38281295-736EDBF9-6C8A-44C5-94BC-B6D1EDE55711Q38614087-6EBD92B7-CA8A-4798-B17B-28DC6E835883Q38767522-5FA89D70-CE02-4306-864A-D152933443CBQ38873909-A0A8DC99-517B-4524-8535-F2B2878386D3Q39009395-F82674A5-AE1E-4853-A5F6-C3CD1B803502Q39094966-204D3FBC-8D04-4242-AE0F-C72F751D9E6CQ39259645-18F54853-6FD8-4C24-A109-D45ADD12FF99Q41992574-D481D16C-D613-4D77-A2D8-5D6AC52D7D4AQ43007314-1EA0E337-CCA6-453F-B4C7-968CAF88136CQ55344422-574FD4E2-58AF-4960-A587-AE24A8C39F80
P2860
Regression of early diabetic macular oedema is associated with prevention of dark adaptation
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Regression of early diabetic m ...... prevention of dark adaptation
@ast
Regression of early diabetic m ...... prevention of dark adaptation
@en
type
label
Regression of early diabetic m ...... prevention of dark adaptation
@ast
Regression of early diabetic m ...... prevention of dark adaptation
@en
prefLabel
Regression of early diabetic m ...... prevention of dark adaptation
@ast
Regression of early diabetic m ...... prevention of dark adaptation
@en
P2093
P2860
P356
P1433
P1476
Regression of early diabetic m ...... prevention of dark adaptation
@en
P2093
P2860
P2888
P304
P356
10.1038/EYE.2011.264
P577
2011-10-21T00:00:00Z